828 Ind. Admin. Code 3-1-5

Current through October 31, 2024
Section 828 IAC 3-1-5 - Training and education programs in light parenteral conscious sedation

Authority: IC 25-14-1-3.1; IC 25-14-1-13

Affected: IC 25-14-1-3.1

Sec. 5.

(a) A predoctoral training program in light parenteral conscious sedation shall meet the following requirements:
(1) Be obtained in a board approved dental school.
(2) Instruction shall include the following areas:
(A) Philosophy of pain control and patient management, including the nature and purpose of pain.
(B) Review of physiologic and psychological aspects of pain and apprehension.
(C) Physiologic monitoring.
(D) Organic pain problems and their management.
(E) Control of preoperative and operative pain and apprehension.
(F) Techniques of administration of light parenteral conscious sedation including intramuscular, intravenous, submucosal, and subcutaneous sedation.
(G) Prevention, recognition, and management of complications and emergencies, including the principles of advanced cardiac life support. Beginning September 1, 1992, instruction shall include training in and successful completion of a course in advanced cardiac life support.
(H) Interaction of pharmacological and psychological methods.
(I) Control of postoperative pain and apprehension.
(3) Each student must have experience in managing a minimum of ten (10) patients.
(b) A postdoctoral training program in light parenteral conscious sedation shall meet the following requirements:
(1) Include a minimum of sixty (60) hours of instruction.
(2) Include management of at least ten (10) patients.
(3) Include the following in the course content:
(A) Historical, philosophical, and psychological aspects of pain and anxiety control.
(B) Patient evaluation and selection through review of medical history taking, physical diagnosis, and psychological profiling.
(C) Definitions and descriptions of physiological and psychological aspects of pain and anxiety.
(D) A description of the stages of drug-induced central nervous system depression through all levels of consciousness and unconsciousness, with special emphasis on the distinction between the conscious and the unconscious state.
(E) Review of respiratory and circulatory physiology and related anatomy.
(F) Pharmacology of agents used in the conscious sedation techniques being taught, including drug interaction and incompatibility.
(G) Indications and contraindications for the use of the conscious sedation modality under consideration.
(H) Review of dental procedures possible under conscious sedation.
(I) Patient monitoring, with particular attention to vital signs and reflexes related to consciousness.
(J) Importance of maintaining proper records with accurate chart entries recording medical history, physical examination, vital signs, drugs administered, and patient response.
(K) Prevention, recognition, and management of complications and life-threatening situations that may occur during use of conscious sedation techniques, including the principles of advanced cardiac life support. Beginning September 1, 1992, instruction shall include training in and successful completion of a course in advanced cardiac life support.
(L) The importance of using local anesthesia in conjunction with conscious sedation techniques.
(M) Venipuncture, including anatomy, armamentarium, and technique.
(N) Sterile techniques in intravenous therapy.
(O) Prevention, recognition, and management of local complications of venipuncture.
(P) Description and rationale for the technique to be employed.
(Q) Prevention, recognition, and management of systemic complications of intravenous sedation, with particular attention to airway maintenance and support of the respiratory and cardiovascular systems.

828 IAC 3-1-5

State Board of Dentistry; 828 IAC 3-1-5; filed Dec 2, 1987, 9:34 a.m.: 11 IR 1290; filed Jun 8, 1992, 5:00 p.m.: 15 IR 2240; readopted filed Apr 11, 2001, 3:21 p.m.: 24 IR 2896; readopted filed Oct 4, 2007, 3:36 p.m.: 20071031-IR-828070047RFA; readopted filed November 25, 2013, 9:23 a.m.: 20131225-IR-828130287RFA
Readopted filed 11/25/2019, 12:11 p.m.: 20191225-IR-828190173RFA